Panbio登革熱NS1檢測(cè)試劑

登革熱NS1抗原快速檢測(cè)試劑

廣州健侖生物科技有限公司

本公司為大家供應(yīng)各種進(jìn)口品牌登革熱檢測(cè)試劑盒，包括澳洲Panbio、美國(guó)NovaBios、美國(guó)CORTEZ等美國(guó)CDC品牌。主要包括膠體金、酶免、PCR等方法學(xué)。歡迎咨詢

Panbio登革熱NS1檢測(cè)試劑 登革熱NS1抗原快速檢測(cè)試劑

非洲工作用登革熱試紙

熱帶國(guó)家旅游用登革熱檢測(cè)試紙

登革熱IgM抗體、登革熱IgG抗體、登革熱NS1抗原、登革熱早期檢測(cè)試劑盒

登革熱核酸檢測(cè)試劑盒

Panbio公司簡(jiǎn)介:
1、1988年成立，2001年在澳大利亞證券交易所上市。
2、Panbio系關(guān)于蟲媒感染性疾病及熱帶感染性疾病的專業(yè)供貨商。
3、產(chǎn)品面向蟲媒感染性疾病的檢測(cè)，在國(guó)內(nèi)疾控系統(tǒng)具有*的認(rèn)知和認(rèn)可度。
4、2010年銷售800萬檢測(cè)試劑，為30多種疾病提供診斷。

Panbio登革熱介紹：

1、登革熱快速檢測(cè)試劑(Dengue Duo Cassette R-DEN03D)
用于定性的快速檢測(cè)人群血清、血漿或全血中登革病毒的IgM及IgG抗體。可在15分鐘內(nèi)檢測(cè)結(jié)果。

2、登革IgM捕捉ELISA(Dengue IgM Capture ELISA E-DEN01M)
用于定性的檢測(cè)人群血清中登革病毒的IgM抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革熱癥狀的病人的輔助診斷。

3、登革IgG捕捉ELISA(Dengo IgG Capture ELISA E-DEN02G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體。用于臨床實(shí)驗(yàn)室對(duì)繼發(fā)登革熱感染的輔助診斷。

4、登革早期ELISA(Dengue Early ELISA E-DEN01P)
用于定性檢測(cè)血清中登革病毒的NS1抗原(血清型1、2、3及4型)。用于臨床實(shí)驗(yàn)室對(duì)有持續(xù)發(fā)燒的登革熱癥狀病人的輔助性診斷。

5、登革IgG間接ELISA(Dengue IgG Indirect ELISA E-DEN01G)
用于定性檢測(cè)血清中登革病毒(血清型1、2、3及4型)的IgG抗體，用于臨床實(shí)驗(yàn)室對(duì)具有持續(xù)發(fā)燒的登革感染癥狀或接觸史的患者的輔助性診斷。

6、登革IgM & IgG聯(lián)檢ELISA(Dengue Duo IgM & IgG Capture ELISA E-DEN01D)
用于定性檢測(cè)血清中登革病毒的IgM和IgG抗體。可以區(qū)分原發(fā)感染與繼發(fā)感染。

Dengue產(chǎn)品介紹

Panbio 登革熱NS1抗原快速檢測(cè)試劑

實(shí)驗(yàn)室及其他檢查
1.一般常規(guī)和生化檢查
外周血白細(xì)胞總數(shù)正常或升高，但在本病早期中性粒細(xì)胞數(shù)常減少。血小板計(jì)數(shù)正常或減少。血清膽紅素、ALT和AST升高，死亡病例更為明顯。有黃疸的病例凝血酶原時(shí)間及部分凝血活酶時(shí)間延長(zhǎng)。尿蛋白增多、血清尿素及肌酐升高。
2.病毒分離
采取病初3～4天內(nèi)血標(biāo)本接種小白鼠腦內(nèi)或細(xì)胞培養(yǎng)可分離出病毒并用血清學(xué)方法進(jìn)行鑒定。
3.血清學(xué)檢查
可作血凝抑制試驗(yàn)、補(bǔ)體結(jié)合試驗(yàn)或中和試驗(yàn)檢測(cè)特異性抗體，急性期與恢復(fù)期雙份血清標(biāo)本4倍以上增高可以診斷本病。目前多采用抗體捕獲酶免疫試驗(yàn)檢測(cè)登革熱病病毒IgM抗體，在感染后一周即呈陽性，有助于早期診斷，早期亦可用抗原捕獲試驗(yàn)檢測(cè)病毒抗原。
4.反轉(zhuǎn)錄/聚合酶鏈反應(yīng)（RT/PCR）
檢測(cè)登革熱病毒RNA有很強(qiáng)的特異性。有報(bào)告血清中病毒RNA較活病毒更為穩(wěn)定，在27℃常溫下能保存相當(dāng)長(zhǎng)時(shí)間，優(yōu)于病毒分離法。
5.其他輔助檢查
心電圖可見PR及QT間期延長(zhǎng)及ST-T波異常。
診斷
對(duì)于典型病例登革熱病的診斷不難，而對(duì)于散發(fā)的、早期或輕型病例不易確診，需借助于實(shí)驗(yàn)室檢查。
鑒別診斷
在登革熱病的診斷過程中應(yīng)注意：與流行性出血熱、鉤端螺旋體病、登革熱、病毒性肝炎、惡性瘧疾及藥物中毒性肝炎等進(jìn)行鑒別。
治療
至今尚無*療法。
1.一般治療
登革熱病的治療應(yīng)臥床休息直至*恢復(fù)，應(yīng)住在無蚊蟲的屋內(nèi)，尤其在病兒發(fā)熱期間Panbio登革熱毒血癥應(yīng)使用蚊帳。給予流質(zhì)或半流質(zhì)飲食，頻繁嘔吐者可禁食、給予靜脈補(bǔ)液，注意水、電解質(zhì)和酸堿平衡。
2.對(duì)癥治療
高熱時(shí)登革熱病的治療宜采用物理降溫為主，禁用阿司匹林退熱，因可誘發(fā)或加重出血。頻繁嘔吐可口服或肌注胃復(fù)安。有繼發(fā)細(xì)菌感染或并發(fā)瘧疾者給予合適的抗生素或抗瘧藥。心肌損害者可試用腎上腺皮質(zhì)激素。對(duì)重癥病例應(yīng)嚴(yán)密觀察病情變化，如發(fā)生休克、急性腎功能衰竭，消化道出血等即予以相應(yīng)處理。
預(yù)后
輕癥患者一般順利恢復(fù)，不留后遺癥。重癥患者的病死率隨每次流行而異，受種族、年齡、其他乙組蟲媒病毒引起的免疫狀態(tài)等多因素影響，可達(dá)30%～50%。
預(yù)防
1.管理好傳染源
由于我國(guó)已經(jīng)發(fā)現(xiàn)輸入性病例，所以登革熱病的預(yù)防應(yīng)加強(qiáng)邊境檢疫，對(duì)于來自疫區(qū)的人員必須出示有效的預(yù)防接種證書，以防止該病傳入我國(guó)。對(duì)來自登革熱病流行區(qū)的人員開展體溫檢測(cè)、醫(yī)學(xué)巡查、流行病學(xué)調(diào)查和醫(yī)學(xué)檢查，重點(diǎn)關(guān)注有發(fā)熱、黃疸等癥狀人員。

Panbio 登革熱NS1抗原快速檢測(cè)試劑

我司還提供其它進(jìn)口或國(guó)產(chǎn)試劑盒：登革熱、瘧疾、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌等試劑盒以及日本生研細(xì)菌分型診斷血清、德國(guó)SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。

想了解更多的Panbio產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

references：

Laboratory and other inspections
1. General routine and biochemical tests
Peripheral white blood cells in the normal or elevated, but in early childhood the number of neutrophils often reduced. Plaet counts are normal or reduced. Serum bilirubin, ALT and AST increased, more serious cases of death. The time of prothrombin time and partial thromboplastin prolongation in patients with jaundice. Increased urinary protein, serum urea and creatinine increased.
2. virus isolation
To take the first 3 to 4 days of the disease blood samples inoculated with the mouse brain or cell culture can be isolated from the virus and serological methods for identification.
3. serological examination
Can be used for hemagglutination inhibition test, complement test or neutralization test to detect specific antibodies, acute phase and convalescence double serum samples more than 4 times higher can diagnose the disease. At present, the use of antibody capture enzyme immunoassay test to detect dengue virus IgM antibodies, one week after infection was positive, contribute to early diagnosis, early antigen detection can also be used to detect viral antigens.
4. Reverse transcription / polymerase chain reaction (RT / PCR)
Detection of dengue virus RNA has a strong specificity. It has been reported that viral RNA in serum is more stable than live virus and can be stored at 27 ℃ for a long time at room temperature, which is superior to virus isolation method.
5. Other auxiliary checks
ECG can be seen PR and QT interval extension and ST-T wave anomalies.
diagnosis
For the typical case of dengue fever diagnosis is not difficult, and for the distribution, early or light cases are not easy to diagnose, need to rely on laboratory tests.
Differential diagnosis
In the diagnosis of dengue fever should pay attention to: and epidemic hemorrhagic fever, leptospirosis, dengue fever, viral hepatitis, falciparum malaria and drug toxicity of hepatitis and other identification.
treatment
There is no special therapy yet.
General treatment
The treatment of dengue fever should be rested until it is fully restored and should live in mosquito-free houses, especially during sick children with fever. Panbio dengue toxins should use mosquito nets. Given fluid or semi-liquid diet, frequent vomiting can be fasting, given intravenous fluid, pay attention to water, electrolyte and acid-base balance.
2. symptomatic treatment
Fever when the treatment of dengue fever should use the main physical cooling, disabling aspirin fever, can induce or increase bleeding. Frequent vomiting can be given orally or intramuscularly. Secondary antibiotics or antimalarials are given to secondary bacterial infections or malaria. Myocardial damage can try adrenal cortex hormones. For severe cases should be closely observed changes in the condition, such as shock, acute renal failure, gastrointestinal bleeding, etc. should be dealt with accordingly.
Prognosis
Mild patients generally successfully recovered, leaving no sequelae. The mortality rate of critically ill patients varies with each epidemic, by the race, age, other B group of insect virus caused by the immune status and other factors, up to 30% to 50%.
prevention
1. Manage the source of infection
As China has found imported cases, so the prevention of dengue fever should strengthen border quarantine, for people from the epidemic area must produce an effective vaccination certificate to prevent the disease into our country. On the dengue fever epidemic area of ??personnel to carry out temperature testing, medical inspection, epidemiological investigation and medical examination, focusing on fever, jaundice and other symptoms.